文献速递神经肌肉病

COL6与LAMA2相关肌营养不良临床结局指标的纵向变化

Longitudinal changes in clinical outcome measures in COL6-related dystrophies and LAMA2-related dystrophies.
PubMed 文献 · Neurology · 2019-10-25

本研究对47例4-22岁COL6-RD或LAMA2-RD患者进行4年随访,评估MFM32、肌力、关节活动度、肺功能和生活质量。结果显示MFM32总分每年分别下降4.01和2.60分,多组肌力及部分关节活动度下降,COL6-RD坐位FVC%预计值每年下降3.03%,生活质量无显著变化。

要点

  • COL6-RD和LAMA2-RD的MFM32总分每年分别下降4.01和2.60分。
  • COL6-RD除肘屈肌外各肌群肌力每年下降1.70%至2.55%。
  • COL6-RD坐位FVC%预计值每年下降3.03%,生活质量无显著变化。

核心结论

  • 本研究描述了COL6-RD和LAMA2-RD患者MFM32、肌力、关节活动度和肺功能的年度变化率。

研究设计与样本

  • 为期4年的纵向观察研究,纳入47例4至22岁患者(COL6-RD 23例,LAMA2-RD 24例)。
  • 评估工具包括MFM32、肌力测定、关节活动度测量、肺功能测试和生活质量量表。
  • 采用线性混合效应模型分析,纳入受试者随机截距。

主要发现

  • COL6-RD和LAMA2-RD的MFM32总分每年分别下降4.01和2.60分(p < 0.01)。
  • COL6-RD除肘屈肌外所有肌群肌力每年下降1.70%(p < 0.05)至2.55%(p < 0.01)。
  • LAMA2-RD左肘关节活动度每年下降3.21°(p < 0.05),COL6-RD右膝伸展每年下降2.35°(p < 0.01)。
  • COL6-RD坐位FVC%预计值每年下降3.03%(p < 0.01)。
  • 生活质量指标分析未见显著变化。

临床怎么用

  • MFM32、肌力、关节活动度和肺功能可作为COL6-RD和LAMA2-RD纵向监测的敏感指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify the rate of change of clinical outcome measures in children with 2 types of congenital muscular dystrophy (CMD), COL6-related dystrophies (COL6-RDs) and LAMA2-related dystrophies (LAMA2-RDs). METHODS: Over the course of 4 years, 47 individuals (23 with COL6-RD and 24 with LAMA2-RD) 4 to 22 years of age were evaluated. Assessments included the Motor Function Measure 32 (MFM32), myometry (knee flexors and extensors, elbow flexors and extensors), goniometry (knee and elbow extension), pulmonary function tests, and quality-of-life measures. Separate linear mixed-effects models were fitted for each outcome measurement, with subject-specific random intercepts. RESULTS: Total MFM32 scores for COL6-RDs and LAMA2-RDs decreased at a rate of 4.01 and 2.60 points, respectively, each year (p < 0.01). All muscle groups except elbow flexors for individuals with COL6-RDs decreased in strength between 1.70% (p < 0.05) and 2.55% (p < 0.01). Range-of-motion measurements decreased by 3.21° (p < 0.05) at the left elbow each year in individuals with LAMA2-RDs and 2.35° (p < 0.01) in right knee extension each year in individuals with COL6-RDs. Pulmonary function demonstrated a yearly decline in sitting forced vital capacity percent predicted of 3.03% (p < 0.01) in individuals with COL6-RDs. There was no significant change in quality-of-life measures analyzed. CONCLUSION: Results of this study describe the rate of change of motor function as measured by the MFM32, muscle strength, range of motion, and pulmonary function in individuals with COL6-RDs and LAMA2-RDs.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Jain MS, Meilleur K, Kim E, et al. Longitudinal changes in clinical outcome measures in COL6-related dystrophies and LAMA2-related dystrophies. Neurology. 2019. PMID: 31653707. doi:10.1212/WNL.0000000000008517

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。